全球行动心电遥测设备市场规模、份额、趋势和成长分析报告（2026-2034年）

预计行动心电遥测设备市场规模将从 2025 年的 20.9 亿美元成长到 2034 年的 56.6 亿美元，2026 年至 2034 年的复合年增长率为 11.72%。

随着对远端患者监护和远端医疗解决方案的需求持续增长，行动心电遥测设备市场预计将迎来显着增长。随着预防保健和慢性病管理的日益重视，行动心电遥测设备正成为医疗服务提供者不可或缺的工具。这些设备能够持续监测患者的心臟活动，从而实现及时干预并改善患者预后。随着技术的进步，行动遥测技术与穿戴式装置和行动应用程式的日益融合将进一步提升心臟护理的可及性和有效性。

随着全球医疗系统努力降低成本并提高病人参与，行动心电遥测设备为心血管健康管理提供了可行的解决方案。这些设备能够实现远端监测，减少患者就诊次数，并使医护人员能够即时追踪患者状况。这项变革不仅提高了病患的便利性，也使医护人员能够基于准确及时的数据做出明智的决策。

展望未来，行动心电遥测设备市场可望迎来一系列创新，进而提升设备功能与使用者体验。数据分析和人工智慧 (AI) 技术的进步将带来更先进的监测能力，进而实现个人化治疗方案和心臟疾病的预防性管理。随着医疗保健格局的不断演变，行动心电遥测设备将在塑造心血管护理的未来中发挥关键作用，确保患者获得及时有效的干预。

目录

第一章 引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 绘製渗透率和成长前景图
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 市场问题
• 波特五力分析
• PESTLE分析

第四章 全球行动心电遥测设备市场（依应用划分）

• 市场分析、洞察与预测
• 铅基
• 基于补丁

5. 全球行动心电遥测设备市场（依适应症划分）

• 市场分析、洞察与预测
• 心绞痛
• 动脉粥状硬化
• 心臟衰竭
• 其他的

6. 全球行动心电遥测设备市场（依最终用户划分）

• 市场分析、洞察与预测
• 医院
• 专科诊所
• 诊断中心
• 居家医疗环境
• 其他的

7. 全球行动心电遥测设备市场（按地区划分）

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商格局（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Biotelemetry Inc
  • Scottcare
  • Biotricity Inc
  • Welch Allyn
  • Applied Cardiac Systems Inc
  • Medicomp Inc
  • Preventice Solutions
  • Telerhythmics LLC
  • Zoll Medical Corporation
  • Irhythm Technologies Inc

The Mobile Cardiac Telemetry Device Market size is expected to reach USD 5.66 Billion in 2034 from USD 2.09 Billion (2025) growing at a CAGR of 11.72% during 2026-2034.

The Mobile Cardiac Telemetry Device market is poised for remarkable growth as the demand for remote patient monitoring and telehealth solutions continues to rise. With an increasing focus on preventive healthcare and the management of chronic conditions, mobile cardiac telemetry devices are becoming essential tools for healthcare providers. These devices enable continuous monitoring of patients' heart activity, allowing for timely interventions and improved patient outcomes. As technology advances, the integration of mobile telemetry with wearable devices and mobile applications will further enhance the accessibility and effectiveness of cardiac care.

As healthcare systems worldwide strive to reduce costs and improve patient engagement, mobile cardiac telemetry devices offer a viable solution for managing cardiovascular health. By enabling remote monitoring, these devices can reduce the need for hospital visits and allow healthcare providers to track patients' conditions in real-time. This shift not only enhances patient convenience but also empowers healthcare professionals to make informed decisions based on accurate and timely data.

Looking ahead, the Mobile Cardiac Telemetry Device market is expected to witness innovations that enhance device functionality and user experience. Developments in data analytics and artificial intelligence will enable more sophisticated monitoring capabilities, allowing for personalized treatment plans and proactive management of cardiac conditions. As the healthcare landscape continues to evolve, mobile cardiac telemetry devices will play a pivotal role in shaping the future of cardiovascular care, ensuring that patients receive timely and effective interventions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

• Lead-Based
• Patch-Based

By Disease Indication

• Angina Pectoris
• Atherosclerosis
• Heart Failure
• Others

By End-User

• Hospitals
• Specialty Clinics
• Diagnostic Centers
• Home Care Settings
• Others

COMPANIES PROFILED

• Biotelemetry Inc, Scottcare, Biotricity Inc, Welch Allyn, Applied Cardiac Systems Inc, Medicomp Inc, Preventice Solutions, Telerhythmics LLC, Zoll Medical Corporation, Irhythm Technologies Inc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MOBILE CARDIAC TELEMETRY DEVICE MARKET: BY APPLICATION 2022-2034 (USD MN and K Units)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. Lead-Based Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 4.3. Patch-Based Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 5. GLOBAL MOBILE CARDIAC TELEMETRY DEVICE MARKET: BY DISEASE INDICATION 2022-2034 (USD MN and K Units)

• 5.1. Market Analysis, Insights and Forecast Disease Indication
• 5.2. Angina Pectoris Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 5.3. Atherosclerosis Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 5.4. Heart Failure Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 6. GLOBAL MOBILE CARDIAC TELEMETRY DEVICE MARKET: BY END-USER 2022-2034 (USD MN and K Units)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 6.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 6.4. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 6.5. Home Care Settings Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 7. GLOBAL MOBILE CARDIAC TELEMETRY DEVICE MARKET: BY REGION 2022-2034(USD MN and K Units)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 7.2.1 By Application
  • 7.2.2 By Disease Indication
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 7.3.1 By Application
  • 7.3.2 By Disease Indication
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 7.4.1 By Application
  • 7.4.2 By Disease Indication
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 7.5.1 By Application
  • 7.5.2 By Disease Indication
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 7.6.1 By Application
  • 7.6.2 By Disease Indication
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL MOBILE CARDIAC TELEMETRY DEVICE INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Biotelemetry Inc
  • 9.2.2 Scottcare
  • 9.2.3 Biotricity Inc
  • 9.2.4 Welch Allyn
  • 9.2.5 Applied Cardiac Systems Inc
  • 9.2.6 Medicomp Inc
  • 9.2.7 Preventice Solutions
  • 9.2.8 Telerhythmics LLC
  • 9.2.9 Zoll Medical Corporation
  • 9.2.10 Irhythm Technologies Inc